newsfilter
← Latest News
GlobeNewswire·

Lexeo Therapeutics Announces Proposed Offering of Common Stock and Pre-Funded Warrants

NEW YORK, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (NASDAQ:LXEO) (the "Lexeo"), a clinical stage genetic medicine company dedicated to pioneering novel treatments for cardiovascular diseases, today